Correction to: Genetic Spectrum in F13A1 Detected by Next-Generation Sequencing Among North Indian Patients with FXIII Deficiency

Correction to: Indian Journal of Hematology and Blood Transfusion https://doi.org/10.1007/s12288-022-01579-1

In the original publication of the article, the columns HGVSc (NM_000129.3) and HGVSp (NP_000120.2) of Table 1 were inadvertently removed from the PDF version of the article.

Table 1.

Details of clinical features, laboratory features, and molecular spectrum of FXIII deficiency

Cases	Age/Sex	AOP	BAT Score	Clinical Phenotype	UCS	FXIII-A (IU/dL)	Genotype	Depth (X)	Variant Type	Exon/Int	HGVSc (NM_000129.3)	HGVSp (NP_000120.2)	Variant Classification	Domain	rs ID [Reference]
Case 1	50/M	10 Yrs	12	SB + JS + TEB + HT	+ ve	2.1	Homo	193	Deletion	4	c.521delG	p.Ser174Ilefs*34	Pathogenic	β sandwich domain	rs774669729 [8, 11]
Case 2*	2/F	1st week of birth	5	SB + UCB	+ ve	3.8	Homo	48	Deletion	6	c.742delA	p.Met248Trpfs*2	Pathogenic	Core domain	Novel
Case 3*	2/M	1st week of birth	4	UCB + PB	+ ve	ND	Homo	53	Nonsense	8	c.1112G > A	p.Trp371*	Pathogenic	Core domain	Novel
Case 4	28/M	1.5 months	6	SB + UCB + IMH	N	6.6	Homo	53	Nonsense	9	c.1127G > A	p.Trp376*	Pathogenic	Core domain	[11]
Case 5*	35/M	20 Yrs	5	SB + JS	+ ve	ND	Homo	56	Nonsense	9	c.1127G > A	p.Trp376*	Pathogenic	Core domain	[11]
Case 6	7/F	6th day of birth	6	SB + OB + UCB	+ ve	ND	Homo	78	Nonsense	9	c.1127G > A	p.Trp376*	Pathogenic	Core domain	[11]
Case 7	7/M	9th day of birth	9	SB + HT + UCB	+ ve	0.7	Homo	56	Missense	10	c.1226G > A	p.Arg409Gln	Likely Pathogenic	Core domain	rs532879106 [5, 10, 11, 19]
Case 8	4/F	11th day of birth	14	SB + UCB	+ ve	0.6	Homo	44	Deletion	11	c.1405_1408delCAAA	p.Gln469Leufs*6	Pathogenic	Core domain	[6]
Case 9	51/M	1st week of birth	11	GI-MA + GU + UCB + ICB	+ ve	6.1	Homo	125	Splice site	14	c.2045G > A	p.Arg682His	Likely Pathogenic	β barrel-2 domain	rs121913064 [5, 7–11]
Case 10	21/F	2 Yrs	4	PB for 9 days	+ ve	ND	C. Het	27	Splice site	14	c.2045G > A	p.Arg682His	Pathogenic	β barrel-2 domain	rs121913064 [5, 7–11]
								27	Splice site	Int 13	c.1909-1G > C		Pathogenic	Pathogenic	Novel
Case 11#	8/M	2nd day of birth	16	IMH + SB + HU + IA/R + UCB	+ ve	0.9	C. Het	33	Missense	15	c.2134A > C	p.Ser712Arg	Likely Pathogenic	β barrel-2 domain	Novel
								98	Missense	5	c.631G > C	p.Gly211Arg	Likely Pathogenic	Core domain	rs1205172031 [7]
Case 12	2 months/M	2 months	5	EP	Inc	37.3	Het	32	Missense	8	c.998C > T	p.Ala333Val	VUS	Core domain	rs759294043
Case 13	67/F	42 Yrs	2	SB + JB + MN	N	49.5	No pathogenic variant was found
Case 14	24/F	13 Yrs	3	GI-MA + MN	N	22.5
Case 15	70/M	67 Yrs	2	SB + GI-MA	+ ve	40.1
Case 16	32/F	30 Yrs	1	RA + SB	+ ve	ND

AOP Age of Presentation, BAT ISTH Bleeding Assessment Tool, EP epistaxis, F female; FXIII-A Antigen Assay Normal range (50–150 IU/dL), GI-MA Gastrointestinal malaena, GU Genitourinary bleed, HU Hematuria, HT Hematoma, IA/R Intraabdominal/Retroperitoneal, ICB Intracranial Bleed, Inc Inconclusive, IMH Intramuscular hematoma, Int Intron, JS Joint Swelling, M Male, MN Menorrhagia, N Normal, ND Not Done, OB Oral Bleed, PB Prolonged wound bleeding, RA Recurrent Abortions, SB Skin Bleed, TEB Tooth extraction bleed, UCB Umbilical cord bleed, VUS Variant of Uncertain Significance, + ve Positive, *- Positive family history, #- consanguineous family. In all solved cases, pathogenic/likely pathogenic variants were identified in F13A1 gene.

The correct Table 1 is given below:

The original article has been corrected.